Activist 13D/13G Filings - Corriente Advisors LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-02-14
4:23 pm
Sale
13GCue Biopharma Inc.
CUE
Corriente Advisors LLC0
0.000%
-1,915,219decrease
(Position Closed)
View
2022-02-14
4:10 pm
Sale
13GTFF PHARMACEUTICALS INC NE
TFFP
Corriente Advisors LLC0
0.000%
-1,350,000decrease
(Position Closed)
View
2022-02-14
4:04 pm
Sale
13GCardiff Oncology Inc.
CRDF
Corriente Advisors LLC0
0.000%
-2,000,000decrease
(Position Closed)
View
2021-02-16
06:33 am
Purchase
13GTFF PHARMACEUTICALS INC NE
TFFP
Corriente Advisors LLC1,350,000
6.070%
1,350,000increase
(New Position)
View
2021-02-16
06:28 am
Purchase
13GCue Biopharma Inc.
CUE
Corriente Advisors LLC1,915,219
6.330%
1,915,219increase
(New Position)
View
2021-02-16
06:26 am
Sale
13GASTRIA THERAPEUTICS INC
ATXS
Corriente Advisors LLC0
0.000%
-804,584decrease
(Position Closed)
View
2021-02-16
06:23 am
Sale
13GBOWFLEX INC.INC.
BFXXQ
Corriente Advisors LLC0
0.000%
-1,813,822decrease
(Position Closed)
View
2021-02-16
06:18 am
Purchase
13GCardiff Oncology Inc.
CRDF
Corriente Advisors LLC2,000,000
5.660%
2,000,000increase
(New Position)
View
2020-02-10
4:07 pm
Purchase
13GASTRIA THERAPEUTICS INC
ATXS
Corriente Advisors LLC804,584
6.710%
201,455increase
(+33.40%)
View
2020-01-23
12:39 pm
Purchase
13GBOWFLEX INC.INC.
BFXXQ
Corriente Advisors LLC1,813,822
6.100%
1,813,822increase
(New Position)
View